1. Home
  2. BVS vs FLGT Comparison

BVS vs FLGT Comparison

Compare BVS & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • FLGT
  • Stock Information
  • Founded
  • BVS 2011
  • FLGT 2011
  • Country
  • BVS United States
  • FLGT United States
  • Employees
  • BVS N/A
  • FLGT N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FLGT Medical Specialities
  • Sector
  • BVS Health Care
  • FLGT Health Care
  • Exchange
  • BVS Nasdaq
  • FLGT Nasdaq
  • Market Cap
  • BVS 496.7M
  • FLGT 588.5M
  • IPO Year
  • BVS 2021
  • FLGT 2016
  • Fundamental
  • Price
  • BVS $6.88
  • FLGT $20.11
  • Analyst Decision
  • BVS Strong Buy
  • FLGT Buy
  • Analyst Count
  • BVS 4
  • FLGT 2
  • Target Price
  • BVS $15.00
  • FLGT $24.00
  • AVG Volume (30 Days)
  • BVS 427.4K
  • FLGT 219.4K
  • Earning Date
  • BVS 08-05-2025
  • FLGT 08-01-2025
  • Dividend Yield
  • BVS N/A
  • FLGT N/A
  • EPS Growth
  • BVS N/A
  • FLGT N/A
  • EPS
  • BVS N/A
  • FLGT N/A
  • Revenue
  • BVS $567,699,000.00
  • FLGT $292,448,000.00
  • Revenue This Year
  • BVS N/A
  • FLGT $11.79
  • Revenue Next Year
  • BVS $6.11
  • FLGT $10.45
  • P/E Ratio
  • BVS N/A
  • FLGT N/A
  • Revenue Growth
  • BVS 8.60
  • FLGT 1.71
  • 52 Week Low
  • BVS $5.62
  • FLGT $14.57
  • 52 Week High
  • BVS $14.38
  • FLGT $25.11
  • Technical
  • Relative Strength Index (RSI)
  • BVS 54.27
  • FLGT 49.73
  • Support Level
  • BVS $6.52
  • FLGT $19.68
  • Resistance Level
  • BVS $7.21
  • FLGT $20.37
  • Average True Range (ATR)
  • BVS 0.27
  • FLGT 0.57
  • MACD
  • BVS 0.06
  • FLGT -0.06
  • Stochastic Oscillator
  • BVS 66.67
  • FLGT 53.40

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Share on Social Networks: